Results 91 to 100 of about 3,210,025 (200)

CORONAVIRUS DISEASE 2019 (COVID-19)

open access: yesJournal of University Medical & Dental College, 2020
The epidemic of 2019 novel coronavirus (2019-nCoV) has been emerged from a major city named Wuhan in the Hubei Province of China. It appears to have the potential to cause a major health problem globally. Earlier it is called 2019-nCoV but now this virus
Aysha Azhar
doaj   +1 more source

Clarifying Vaccination Status, Response Rate, and Regression Estimates in a National COVID‐19 Survey From the Democratic Republic of the Congo

open access: yes
Health Science Reports, Volume 9, Issue 9, September 2026.
Muhammad Mujtaba Rasool   +5 more
wiley   +1 more source

Learning under lockdown: A global synthesis of postsecondary disability research in the COVID‐19 era (2020–2024)

open access: yesJournal of Research in Special Educational Needs, Volume 26, Issue 3, July 2026.
Abstract The COVID‐19 pandemic disrupted universities across the world, amplifying pre‐existing accessibility gaps that disproportionately impact postsecondary students with disabilities. This PRISMA‐guided systematic review synthesized 74 peer‐reviewed studies published between January 2020 and December 2024 focusing on research related to the ...
Nicholas W. Gelbar   +5 more
wiley   +1 more source

Structure analysis of the receptor binding of 2019-nCoV

open access: yesBiochemical and Biophysical Research Communications, 2020
2019-nCoV is a newly identified coronavirus with high similarity to SARS-CoV. We performed a structural analysis of the receptor binding domain (RBD) of spike glycoprotein responsible for entry of coronaviruses into host cells. The RBDs from the two viruses share 72% identity in amino acid sequences, and molecular simulation reveals highly similar ...
Chen, Yun   +3 more
openaire   +2 more sources

Potentially highly potent drugs for 2019-nCoV [PDF]

open access: yes, 2020
Abstract The World Health Organization (WHO) has declared the 2019 novel coronavirus (2019-nCoV) infection outbreak a global health emergency. Currently, there is no effective anti-2019-nCoV medication. The sequence identity of the 3CL proteases of 2019-nCoV and SARS is 96%, which provides a sound foundation for structural-based drug ...
Nguyen, Duc Duy   +4 more
openaire   +2 more sources

Booster mRNA Vaccination Prevents Breakthrough Severe COVID‐19 Infections

open access: yesJournal of Medical Virology, Volume 98, Issue 6, June 2026.
ABSTRACT This study aimed to assess the humoral immune response following administration of a BNT162b2 mRNA COVID‐19 booster dose and to evaluate its association with the development of SARS‐CoV‐2 infection after vaccination. Between July 2021 and February 2022, serum samples were collected from 313 individuals 28 days after receiving a COVID‐19 ...
Harika Öykü Dinç   +12 more
wiley   +1 more source

Nursing management of 2019-nCoV pneumonia patients in Emergency Department [PDF]

open access: yesJichu yixue yu linchuang, 2020
The 2019-nCoV infected pneumonia is an acute respiratory infectious disease with strong infectivity. The Emergency Department of West China Hospital of Sichuan University is the key department of screening and diagnosis of novel coronavirus pneumonia ...
ZHANG Jing-min, GAO Yong-li
doaj  

Role of the Eye in Transmitting Human Coronavirus: What We Know and What We Do Not Know

open access: yesFrontiers in Public Health, 2020
The outbreak of the current 2019 novel coronavirus (2019-nCoV, now named SARS-CoV-2) infection has become a worldwide health threat. Currently, more information is needed so as to further understand the transmission and clinical characteristics of 2019 ...
Chuan-bin Sun   +3 more
doaj   +1 more source

BPMN Extensions Updated: A Systematic Literature Review

open access: yesJournal of Software: Evolution and Process, Volume 38, Issue 6, June 2026.
ABSTRACT Business process model and notation (BPMN) is a widely used modeling language for representing business processes. BPMN has been extended to represent particular domains or application areas, or to improve practical aspects. BPMN extensions have been the subject of recent studies.
Milene Cavalcante   +2 more
wiley   +1 more source

Immunosenescence and Vaccine Efficacy in Aging: Dynamic Interplay of Gut Microbiota and mTOR Signaling Pathways

open access: yesAging Cell, Volume 25, Issue 6, June 2026.
Aging impairs vaccine efficacy through gut microbiota dysbiosis and mTOR hyperactivation, which together drive inflammaging and weaken immune memory. This review highlights the bidirectional microbiota–mTOR axis and proposes that combining mTOR inhibitors with microbiota modulation offers a promising strategy to enhance vaccine responses in older ...
Jiaxuan Li   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy